logo

Crinetics Pharmaceuticals Inc (CRNX)



Trade CRNX now with
  Date
  Headline
5/21/2019 7:34:08 AM Crinetics Pharma Initiates Phase 1 Study Of CRN01941 For Neuroendocrine Tumors
3/19/2019 7:36:02 AM Crinetics Pharma Doses First Patients In Phase 2 Clinical Trials Of CRN00808 For Acromegaly
3/18/2019 7:40:52 AM Crinetics Pharma Appoints Gina Ford As VP, Corporate Strategy And Commercial Planning
8/30/2018 4:12:44 PM Crinetics Pharmaceuticals Q2 Loss/share $2.41 Vs. Loss $1.22 Year Ago
7/16/2018 2:52:55 AM This Week's Biotech IPOs